Group One Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-56,437
| Closed | -$1.01M | – | 6852 |
|
|
2020
Q2 | $1.01M | Sell |
56,437
-34,158
| -38% | -$475K | ﹤0.01% | 2000 |
|
|
2020
Q1 | $646K | Buy |
90,595
+66,613
| +278% | +$831K | 0.01% | 1863 |
|
|
2019
Q4 | $573K | Buy |
+23,982
| New | +$662K | ﹤0.01% | 2327 |
|
|
2019
Q2 | – | Sell |
-9,092
| Closed | -$285K | – | 5654 |
|
|
2019
Q1 | $315K | Sell |
9,092
-36,774
| -80% | -$1.06M | ﹤0.01% | 2339 |
|
|
2018
Q4 | $895K | Buy |
45,866
+4,451
| +11% | +$91.5K | 0.01% | 1587 |
|
|
2018
Q3 | $1.1M | Buy |
41,415
+21,565
| +109% | +$704K | 0.01% | 1630 |
|
|
2018
Q2 | $750K | Sell |
19,850
-90,009
| -82% | -$3.44M | 0.01% | 1970 |
|
|
2018
Q1 | $3.59M | Sell |
109,859
-5,434
| -5% | -$238K | 0.04% | 643 |
|
|
2017
Q4 | $5.61M | Buy |
115,293
+10,465
| +10% | +$529K | 0.04% | 584 |
|
|
2017
Q3 | $5.66M | Buy |
104,828
+40,655
| +63% | +$2.39M | 0.05% | 455 |
|
|
2017
Q2 | $3.6M | Buy |
64,173
+16,185
| +34% | +$648K | 0.04% | 626 |
|
|
2017
Q1 | $1.88M | Buy |
47,988
+22,822
| +91% | +$727K | 0.02% | 906 |
|
|
2016
Q4 | $565K | Buy |
25,166
+6,770
| +37% | +$132K | 0.01% | 1682 |
|
|
2016
Q3 | $418K | Buy |
18,396
+12,514
| +213% | +$294K | ﹤0.01% | 1948 |
|
|
2016
Q2 | $139K | Sell |
5,882
-248
| -4% | -$6.12K | ﹤0.01% | 2644 |
|
|
2016
Q1 | $125K | Buy |
6,130
+1,928
| +46% | +$61.2K | ﹤0.01% | 2673 |
|
|
2015
Q4 | $216K | Buy |
4,202
+2,439
| +138% | +$118K | ﹤0.01% | 2444 |
|
|
2015
Q3 | $75K | Buy |
+1,763
| New | +$85.1K | ﹤0.01% | 3257 |
|
|
2015
Q2 | – | Sell |
-1,339
| Closed | -$53.9K | – | 5340 |
|
|
2015
Q1 | $51K | Sell |
1,339
-9,852
| -88% | -$338K | ﹤0.01% | 3354 |
|
|
2014
Q4 | $317K | Buy |
11,191
+7,500
| +203% | +$209K | ﹤0.01% | 1918 |
|
|
2014
Q3 | $93K | Sell |
3,691
-696
| -16% | -$18.3K | ﹤0.01% | 3069 |
|
|
2014
Q2 | $128K | Buy |
+4,387
| New | +$106K | ﹤0.01% | 2772 |
|
Group One Trading's PTLA Position: Q3 2020 in Review
Group One Trading sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 56,437 shares — an estimated $1.01M sold.
Group One Trading first reported a position in PTLA in Q2 2014 and held it in 22 quarters. The position peaked at $5.66M in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Group One Trading reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Group One Trading sold 56,437 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.01M.
- Group One Trading first reported a position in Portola Pharmaceuticals, Inc. in Q2 2014 and held it in 22 quarters.
- Group One Trading's Portola Pharmaceuticals, Inc. position peaked at $5.66M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Group One Trading's 13F filing for Q3 2020, filed 12 Nov 2020.